Form 4 for LIN Linde plc
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-03 · accession 0001707925-25-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-04 | 2025-03-03 | LIN | Strauss David P | Executive VP, Chief HR Off | M - OptEx | $154.00 | +7,545 | 8,845 | +580% | +$1.16M |
| D | 2025-03-04 | 2025-03-03 | LIN | Strauss David P | Executive VP, Chief HR Off | S - Sale+OE | $469.74 | -2,477 | 1,300 | -66% | -$1.16M |
| D | 2025-03-04 | 2025-03-03 | LIN | Strauss David P | Executive VP, Chief HR Off | F - Tax | $469.95 | -5,068 | 3,777 | -57% | -$2.38M |
| D | 2025-03-04 | 2025-03-03 | LIN | Strauss David P | Executive VP, Chief HR Off | M - OptEx | $0.00 | -7,545 | 7,545 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-03 | M | A | 7,545 | $154.00 | 8,844.90 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-03-03 | S | D | 2,477 | $469.74 | 1,299.90 | D | — | — | (F2) The price reported is the weighted average sale price. The sale prices ranged from $469.72 to $469.95. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Ordinary Shares | 2025-03-03 | F | D | 5,068 | $469.95 | 3,776.90 | D | — | — | (F1) Ordinary shares withheld to cover exercise price and tax withholdings. |
| 4 | Derivative | Stock Options (right to buy) | 2025-03-03 | M | D | 7,545 | $0.00 | 7,545 | D | $154.00 · — to 2028-02-27 | 7,545 Ordinary Shares | (F13) This option vested in full three years after the grant date. |